BIO-RAD LABORATORIES, INC. (BIO)

Every figure below is the company's own, as filed. Nothing is estimated and nothing is smoothed — a period the filing does not support is left blank rather than drawn. Quarters are the company's own, counted from its financial year ending 12-31. Amounts in USD.

Revenue Quarterly

0 300M 600M 900M Q1 '09: 400.9M Q2 '09: 427.2M Q3 '09: 461.1M Q4 '09: 495.1M Q1 '10: 454.2M Q2 '10: 467.7M Q3 '10: 471.5M Q4 '10: 533.7M Q1 '11: 485.1M Q2 '11: 521.7M Q3 '11: 516.5M Q4 '11: 550.2M Q1 '12: 486.3M Q2 '12: 510.4M Q3 '12: 498.7M Q4 '12: 573.8M Q1 '13: 499.7M Q2 '13: 525.3M Q3 '13: 505.1M Q4 '13: 602.6M Q1 '14: 509.3M Q2 '14: 536.8M Q3 '14: 530.6M Q4 '14: 598.2M Q1 '15: 472.8M Q2 '15: 506.1M Q3 '15: 470M Q4 '15: 570.6M Q1 '16: 471.2M Q2 '16: 516.8M Q3 '16: 508.7M Q4 '16: 571.5M Q1 '17: 500.1M Q2 '17: 504.7M Q3 '17: 534.1M Q4 '17: 621.3M Q1 '18: 551.5M Q2 '18: 575.9M Q3 '18: 545.1M Q4 '18: 616.8M Q1 '19: 554M Q2 '19: 572.6M Q3 '19: 560.6M Q4 '19: 624.5M Q1 '20: 571.6M Q2 '20: 536.9M Q3 '20: 647.3M Q4 '20: 789.8M Q1 '21: 726.8M Q2 '21: 715.9M Q3 '21: 747M Q4 '21: 732.7M Q1 '22: 700.1M Q2 '22: 691.1M Q3 '22: 680.8M Q4 '22: 730.2M Q1 '23: 676.8M Q2 '23: 681.1M Q3 '23: 632.1M Q4 '23: 681.1M Q1 '24: 610.8M Q2 '24: 638.5M Q3 '24: 649.7M Q4 '24: 667.5M Q1 '25: 585.4M Q2 '25: 651.6M Q3 '25: 653M Q4 '25: 693.2M Q1 '26: 592.1M Q2 '26: 651M Q3 '10 Q4 '12 Q1 '15 Q2 '17 Q3 '19 Q4 '21 Q1 '24 Q2 '26

Gross Profit Quarterly

0 200M 400M 600M Q1 '09: 228.9M Q2 '09: 242M Q3 '09: 260.5M Q4 '09: 268.5M Q1 '10: 257.1M Q2 '10: 268.3M Q3 '10: 266.3M Q4 '10: 299.7M Q1 '11: 277.6M Q2 '11: 293.1M Q3 '11: 296.2M Q4 '11: 311M Q1 '12: 278.6M Q2 '12: 287.9M Q3 '12: 273.8M Q4 '12: 314.1M Q1 '13: 271.4M Q2 '13: 300.1M Q3 '13: 284.2M Q4 '13: 322.7M Q1 '14: 275.3M Q2 '14: 297.2M Q3 '14: 288.6M Q4 '14: 317.4M Q1 '15: 270.1M Q2 '15: 279.6M Q3 '15: 263.5M Q4 '15: 308.5M Q1 '16: 264M Q2 '16: 280.2M Q3 '16: 279.5M Q4 '16: 314.4M Q1 '17: 270.1M Q2 '17: 273.4M Q3 '17: 299M Q4 '17: 345.2M Q1 '18: 302.2M Q2 '18: 301.7M Q3 '18: 286.7M Q4 '18: 332.6M Q1 '19: 311.8M Q2 '19: 307.8M Q3 '19: 307M Q4 '19: 330.4M Q1 '20: 317.4M Q2 '20: 293M Q3 '20: 367.3M Q4 '20: 460.1M Q1 '21: 400.6M Q2 '21: 401.6M Q3 '21: 437.4M Q4 '21: 399.9M Q1 '22: 402.6M Q2 '22: 395M Q3 '22: 372.6M Q4 '22: 397.1M Q1 '23: 362.4M Q2 '23: 362.5M Q3 '23: 335.7M Q4 '23: 366.3M Q1 '24: 325.9M Q2 '24: 355.1M Q3 '24: 355.9M Q4 '24: 342M Q1 '25: 306M Q2 '25: 345.3M Q3 '25: 343.4M Q4 '25: 345.2M Q1 '26: 309.4M Q2 '26: 345.8M Q3 '10 Q4 '12 Q1 '15 Q2 '17 Q3 '19 Q4 '21 Q1 '24 Q2 '26

Operating Income Quarterly

-70M 0 70M 140M 210M Q1 '09: 51.4M Q2 '09: 55.9M Q3 '09: 67.4M Q4 '09: 56.3M Q1 '10: 63.2M Q2 '10: 68.2M Q3 '10: 74.8M Q4 '10: 77.8M Q1 '11: 67.1M Q2 '11: 68.2M Q3 '11: 73.9M Q4 '11: 96M Q1 '12: 54.4M Q2 '12: 73.3M Q3 '12: 65.8M Q4 '12: 67.1M Q1 '13: 35.2M Q2 '13: 52.9M Q3 '13: 29.1M Q4 '13: 52.3M Q1 '14: 20.5M Q2 '14: 45.7M Q3 '14: 33.2M Q4 '14: 50.6M Q1 '15: 34.3M Q2 '15: 40.2M Q3 '15: 32.7M Q4 '15: 59.5M Q1 '16: 25.7M Q2 '16: 22.5M Q3 '16: 28.1M Q4 '16: -28.2M Q1 '17: 26.2M Q2 '17: -1.7M Q3 '17: 38.8M Q4 '17: 45.9M Q1 '18: 43.6M Q2 '18: 43.8M Q3 '18: 36.3M Q1 '19: 56.6M Q2 '19: 56.4M Q3 '19: 57.5M Q4 '19: 59.2M Q1 '20: 74.4M Q2 '20: 51.7M Q3 '20: 109.6M Q4 '20: 185.6M Q1 '21: 100.9M Q2 '21: 124.8M Q3 '21: 156.8M Q4 '21: 117.9M Q1 '22: 146.4M Q2 '22: 122.9M Q3 '22: 94.6M Q4 '22: 118.7M Q1 '23: 61.9M Q2 '23: 89.6M Q3 '23: 90.9M Q4 '23: 95.3M Q1 '24: 44.6M Q2 '24: 101.5M Q3 '24: 64.5M Q4 '24: 58.3M Q1 '25: 23.7M Q2 '25: 77.1M Q3 '25: 65.3M Q1 '26: 34.1M Q2 '26: 72.6M Q1 '10 Q2 '12 Q3 '14 Q4 '16 Q2 '19 Q3 '21 Q4 '23 Q2 '26

Net Income Quarterly

-4.5B -3B -1.5B 0 1.5B 3B 4.5B Q1 '09: 30.3M Q2 '09: 38M Q3 '09: 38.5M Q4 '09: 37.9M Q1 '10: 34.9M Q2 '10: 38M Q3 '10: 44.8M Q4 '10: 67.9M Q1 '11: 33M Q2 '11: 40M Q3 '11: 45.9M Q4 '11: 59.2M Q1 '12: 31M Q2 '12: 48.3M Q3 '12: 42.6M Q4 '12: 42M Q1 '13: 20.2M Q2 '13: 34.6M Q3 '13: -7.1M Q4 '13: 30.1M Q1 '14: 6.7M Q2 '14: 31.6M Q3 '14: 11.5M Q4 '14: 39M Q1 '15: 17.8M Q2 '15: 28.4M Q3 '15: 17.4M Q4 '15: 49.5M Q1 '16: 12.3M Q2 '16: 18M Q3 '16: 18.4M Q4 '16: -18.7M Q1 '17: 12.4M Q2 '17: 5M Q3 '17: 22.1M Q4 '17: 82.7M Q1 '18: 656.8M Q2 '18: 268M Q3 '18: 269.3M Q4 '18: -828.5M Q1 '19: 865.2M Q2 '19: 598.8M Q3 '19: -258.8M Q4 '19: 553.5M Q1 '20: 685.9M Q2 '20: 966.4M Q3 '20: 1.3B Q4 '20: 839.2M Q1 '21: 977.4M Q2 '21: 914.1M Q3 '21: 3.9B Q4 '21: -1.6B Q1 '22: -3.4B Q2 '22: -925.1M Q3 '22: -162.8M Q4 '22: 827.7M Q1 '23: 69M Q2 '23: -1.2B Q3 '23: 106.3M Q4 '23: 349.7M Q1 '24: 383.9M Q2 '24: -2.2B Q3 '24: 653.2M Q4 '24: -715.8M Q1 '25: 64M Q2 '25: 317.8M Q3 '25: -341.9M Q4 '25: 720M Q1 '26: -527.1M Q2 '26: 371.4M Q3 '10 Q4 '12 Q1 '15 Q2 '17 Q3 '19 Q4 '21 Q1 '24 Q2 '26

Cost of Revenue Quarterly

0 150M 300M 450M Q1 '17: 230M Q2 '17: 231.3M Q3 '17: 235.1M Q4 '17: 276M Q1 '18: 249.3M Q2 '18: 274.2M Q3 '18: 258.4M Q4 '18: 284.3M Q1 '19: 242.2M Q2 '19: 264.9M Q3 '19: 253.6M Q4 '19: 294M Q1 '20: 254.3M Q2 '20: 243.9M Q3 '20: 280M Q4 '20: 329.6M Q1 '21: 326.2M Q2 '21: 314.3M Q3 '21: 309.6M Q4 '21: 334.3M Q1 '22: 297.4M Q2 '22: 296.1M Q3 '22: 308.2M Q4 '22: 333.2M Q1 '23: 314.4M Q2 '23: 318.6M Q3 '23: 296.4M Q4 '23: 314.8M Q1 '24: 284.9M Q2 '24: 283.4M Q3 '24: 293.8M Q4 '24: 325.6M Q1 '25: 279.4M Q2 '25: 306.3M Q3 '25: 309.6M Q4 '25: 348M Q1 '26: 282.7M Q2 '26: 305.2M Q3 '17 Q4 '18 Q1 '20 Q2 '21 Q3 '22 Q4 '23 Q1 '25 Q2 '26

Operating Cash Flow Quarterly

-150M 0 150M 300M 450M Q3 '09: 97.5M Q4 '09: 115.7M Q1 '10: 22.3M Q2 '10: 36.4M Q3 '10: 66.9M Q4 '10: 100.4M Q1 '11: 19.8M Q2 '11: 110.3M Q3 '11: 51.2M Q4 '11: 81.5M Q1 '12: 35.3M Q2 '12: 73.6M Q3 '12: 71.3M Q4 '12: 86.2M Q1 '13: 24M Q2 '13: 19.7M Q3 '13: 54.8M Q4 '13: 70.5M Q1 '14: 65.6M Q2 '14: 76.9M Q3 '14: 90.7M Q4 '14: 40.2M Q1 '15: 29.4M Q2 '15: 38.5M Q3 '15: 82.3M Q4 '15: 36M Q1 '16: -7.4M Q2 '16: 77.2M Q3 '16: 51.6M Q4 '16: 94.8M Q1 '17: -56.2M Q2 '17: 62.5M Q3 '17: 28.5M Q4 '17: 69.4M Q1 '18: 40.3M Q2 '18: 77.9M Q3 '18: 62.3M Q4 '18: 105M Q1 '19: 42.9M Q2 '19: 155.4M Q3 '19: 99.8M Q4 '19: 159.8M Q1 '20: 62.8M Q2 '20: 92.1M Q3 '20: 135.7M Q4 '20: 294.4M Q1 '21: 113.6M Q2 '21: 154.6M Q3 '21: 230.4M Q4 '21: 170.9M Q1 '22: 50.5M Q2 '22: 53.3M Q3 '22: 11M Q4 '22: 79.6M Q1 '23: 98.1M Q2 '23: 98.1M Q3 '23: 97.7M Q4 '23: 81M Q1 '24: 69.8M Q2 '24: 97.6M Q3 '24: 163.6M Q4 '24: 124.2M Q1 '25: 129.9M Q2 '25: 116.5M Q3 '25: 120.9M Q4 '25: 164.9M Q1 '26: 108.1M Q2 '26: 98.7M Q3 '10 Q4 '12 Q1 '15 Q2 '17 Q3 '19 Q4 '21 Q1 '24 Q2 '26

Free Cash Flow Quarterly

-180M -90M 0 90M 180M 270M Q3 '09: 82M Q4 '09: 97.9M Q1 '10: 5.9M Q2 '10: 17.2M Q3 '10: 46.5M Q4 '10: 68.2M Q1 '11: 2M Q2 '11: 85.6M Q3 '11: 26.5M Q4 '11: 45.8M Q1 '12: 606K Q2 '12: 32.6M Q3 '12: 34.7M Q4 '12: 55.7M Q1 '13: -10.1M Q2 '13: -4.8M Q3 '13: 34.5M Q4 '13: 42.8M Q1 '14: 43M Q2 '14: 45.9M Q3 '14: 63.3M Q4 '14: 82K Q1 '15: 2.4M Q2 '15: 6.3M Q3 '15: 57.5M Q4 '15: 8M Q1 '16: -32.7M Q2 '16: 45.6M Q3 '16: 12.1M Q4 '16: 49.6M Q1 '17: -95.5M Q2 '17: 36.9M Q3 '17: 8.2M Q4 '17: 43.3M Q1 '18: 13.2M Q2 '18: 51.1M Q3 '18: 40.2M Q4 '18: 51.1M Q1 '19: 19.3M Q2 '19: 133.2M Q3 '19: 68.7M Q4 '19: 138.2M Q1 '20: 41.2M Q2 '20: 74M Q3 '20: 115.7M Q4 '20: 245.5M Q1 '21: 94.1M Q2 '21: 131.2M Q3 '21: 195.7M Q4 '21: 114.7M Q1 '22: 17.4M Q2 '22: 35.9M Q3 '22: -16.5M Q4 '22: 44.8M Q1 '23: 62.4M Q2 '23: 63.4M Q3 '23: 53.6M Q4 '23: 38.7M Q1 '24: 29.6M Q2 '24: 55.3M Q3 '24: 123.4M Q4 '24: 81.3M Q1 '25: 95.5M Q2 '25: 70.8M Q3 '25: 89.2M Q4 '25: 119.1M Q1 '26: 78.1M Q2 '26: 66.7M Q3 '10 Q4 '12 Q1 '15 Q2 '17 Q3 '19 Q4 '21 Q1 '24 Q2 '26

Operating cash flow minus capital expenditure.

Shares Outstanding Quarterly

0 15M 30M 45M Q2 '09: 27.7M Q3 '09: 27.9M Q1 '10: 28.1M Q2 '10: 28.1M Q3 '10: 28.1M Q1 '11: 28.4M Q2 '11: 28.5M Q3 '11: 28.5M Q1 '12: 28.6M Q2 '12: 28.6M Q3 '12: 28.6M Q1 '13: 28.8M Q2 '13: 28.9M Q3 '13: 28.6M Q1 '14: 29.1M Q2 '14: 29.1M Q3 '14: 29.1M Q1 '15: 29.3M Q2 '15: 29.4M Q3 '15: 29.4M Q1 '16: 29.5M Q2 '16: 29.6M Q3 '16: 29.7M Q1 '17: 29.9M Q2 '17: 30M Q3 '17: 30.1M Q1 '18: 30.2M Q2 '18: 30.2M Q3 '18: 30.3M Q1 '19: 30.1M Q2 '19: 30.2M Q3 '19: 29.8M Q1 '20: 30.2M Q2 '20: 30.1M Q3 '20: 30.1M Q1 '21: 30.2M Q2 '21: 30.1M Q3 '21: 30.2M Q1 '22: 29.9M Q2 '22: 29.8M Q3 '22: 29.7M Q1 '23: 29.7M Q2 '23: 29.4M Q3 '23: 29.2M Q1 '24: 28.5M Q2 '24: 28.4M Q3 '24: 28M Q1 '25: 28M Q2 '25: 27.2M Q3 '25: 26.9M Q1 '26: 27M Q2 '26: 26.8M Q1 '10 Q2 '12 Q3 '14 Q1 '17 Q2 '19 Q3 '21 Q1 '24 Q2 '26

Weighted average diluted, as the filer reports it for each period. An average cannot be added across periods, so this one is always shown per period the filer tagged rather than as a trailing year.

EPS TTM

-240.00 -160.00 -80.00 0.00 80.00 160.00 240.00 Q4 '09: 5.20 Q1 '10: 5.34 Q2 '10: 5.32 Q3 '10: 5.53 Q4 '10: 6.59 Q1 '11: 6.51 Q2 '11: 6.57 Q3 '11: 6.59 Q4 '11: 6.26 Q1 '12: 6.19 Q2 '12: 6.47 Q3 '12: 6.35 Q4 '12: 5.73 Q1 '13: 5.34 Q2 '13: 4.85 Q3 '13: 3.11 Q4 '13: 2.69 Q1 '14: 2.22 Q2 '14: 2.11 Q3 '14: 2.75 Q4 '14: 3.05 Q1 '15: 3.43 Q2 '15: 3.31 Q3 '15: 3.51 Q4 '15: 3.85 Q1 '16: 3.66 Q2 '16: 3.30 Q3 '16: 3.33 Q4 '16: 1.02 Q1 '17: 1.01 Q2 '17: 0.57 Q3 '17: 0.68 Q4 '17: 4.06 Q1 '18: 25.42 Q2 '18: 34.12 Q3 '18: 42.28 Q4 '18: 11.80 Q1 '19: 18.77 Q2 '19: 29.76 Q3 '19: 12.19 Q4 '19: 58.23 Q1 '20: 52.21 Q2 '20: 64.50 Q3 '20: 116.82 Q4 '20: 126.32 Q1 '21: 135.98 Q2 '21: 134.15 Q3 '21: 220.47 Q4 '21: 140.12 Q1 '22: -4.76 Q2 '22: -66.20 Q3 '22: -201.64 Q4 '22: -121.32 Q1 '23: -6.50 Q2 '23: -14.97 Q3 '23: -5.85 Q4 '23: -21.49 Q1 '24: -10.36 Q2 '24: -47.03 Q3 '24: -27.33 Q4 '24: -65.04 Q1 '25: -76.20 Q2 '25: 11.73 Q3 '25: -24.31 Q4 '25: 27.65 Q1 '26: 5.81 Q2 '26: 7.99 Q3 '10 Q4 '12 Q1 '15 Q2 '17 Q3 '19 Q4 '21 Q1 '24 Q2 '26

The filer's own published earnings a share for each quarter, four quarters added up. The company page divides trailing net income by the share count instead, which lands within about 1% of this and is not the same sum, so the two are named differently rather than presented as one figure.